An overseas biotech company is injecting a healthy dose of optimism into the Boston area's recovering life sciences market after signing a full-building deal for a new global headquarters and manufacturing hub.

An overseas biotech company is injecting a healthy dose of optimism into the Boston area's recovering life sciences market after signing a full-building deal for a new global headquarters and manufacturing hub.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
Real Estate